Your browser is no longer supported. Please, upgrade your browser.
Settings
NVTA Invitae Corporation daily Stock Chart
NVTA [NYSE]
Invitae Corporation
Index- P/E- EPS (ttm)-1.79 Insider Own1.50% Shs Outstand91.25M Perf Week7.07%
Market Cap2.21B Forward P/E- EPS next Y-1.53 Insider Trans-9.66% Shs Float85.59M Perf Month13.66%
Income-130.90M PEG- EPS next Q-0.48 Inst Own79.80% Short Float9.25% Perf Quarter6.04%
Sales160.60M P/S13.76 EPS this Y-20.90% Inst Trans1.25% Short Ratio4.42 Perf Half Y69.13%
Book/sh3.99 P/B6.07 EPS next Y19.00% ROA-40.80% Target Price27.13 Perf Year190.76%
Cash/sh3.08 P/C7.86 EPS next 5Y8.00% ROE-65.80% 52W Range7.73 - 26.77 Perf YTD118.99%
Dividend- P/FCF- EPS past 5Y-18.20% ROI-50.00% 52W High-9.53% Beta2.49
Dividend %- Quick Ratio7.70 Sales past 5Y297.90% Gross Margin48.10% 52W Low213.32% ATR1.27
Employees884 Current Ratio7.70 Sales Q/Q46.60% Oper. Margin-76.10% RSI (14)62.72 Volatility6.29% 5.95%
OptionableYes Debt/Eq0.25 EPS Q/Q28.50% Profit Margin-81.50% Rel Volume0.87 Prev Close24.78
ShortableYes LT Debt/Eq0.24 EarningsAug 06 AMC Payout- Avg Volume1.79M Price24.22
Recom1.70 SMA206.50% SMA5019.08% SMA20036.88% Volume1,565,142 Change-2.26%
Mar-04-19Initiated Chardan Capital Markets Buy $29
Dec-19-18Initiated Oppenheimer Outperform
Nov-20-18Resumed The Benchmark Company Buy $17
Feb-13-18Reiterated The Benchmark Company Buy $11 → $10
Jan-16-18Reiterated The Benchmark Company Buy $16 → $11
Jan-16-18Reiterated Leerink Partners Outperform $12 → $10
Jan-05-18Initiated Ladenburg Thalmann Buy $15
Apr-03-17Reiterated The Benchmark Company Buy $11 → $16
Feb-14-17Upgrade The Benchmark Company Hold → Buy $8.50 → $11
Nov-10-16Resumed Leerink Partners Outperform
Jun-30-16Initiated The Benchmark Company Hold $8.50
Jan-28-16Downgrade Leerink Partners Outperform → Mkt Perform
Aug-14-15Initiated William Blair Mkt Perform
May-14-15Upgrade Leerink Partners Mkt Perform → Outperform
Jul-17-19 03:41PM  5 Top Stock Trades for Thursday: TSLA, GLD, ABT InvestorPlace
01:26PM  [video]Invitae Shares Rise After Famed Short-Seller Andrew Left Goes Long the Stock TheStreet.com
Jul-12-19 05:50PM  Invitae (NVTA) Stock Sinks As Market Gains: What You Should Know Zacks
04:29PM  Nasdaq Today: Amazon Prime Day; Facebook Settles With FTC InvestorPlace
12:31PM  InVitae Analyst: Acquisition Beefs Up Company's Hereditary Cancer Testing Capacity Benzinga
Jul-11-19 04:06PM  Invitae to Acquire Jungla to Advance Genetic Variant Interpretation, Adds Supplemental RNA Analysis to Deliver Deeper, More Informative Results to Patients PR Newswire
Jul-04-19 10:26AM  3 Healthcare Stocks Ready to Grow TipRanks
Jul-01-19 10:55AM  Invitae (NVTA) Catches Eye: Stock Jumps 9.1% Zacks
09:15AM  Stocks Soar 7% in June Zacks
Jun-27-19 02:00PM  Capital Market Laboratories (CMLviz) Interviews Invitaes CEO Invitaes Non-Invasive Prenatal Screening Tests Can be a 50% Gross Margin Business GlobeNewswire +6.79%
Jun-24-19 04:23PM  Why These Innovative Biotech ETFs Soaring Zacks
Jun-21-19 03:19PM  5 Top Stock Trades for Monday: AAPL, XOM, NVTA InvestorPlace
10:42AM  The Zacks Analyst Blog Highlights: Invitae, Illumina, Pacific Biosciences and Guardant Health Zacks
Jun-20-19 09:00PM  Invitae Reports Inducement Grants Under NYSE Rule 303A.08 to Former Employees of Singular Bio, Inc. in Connection with Closing of Acquisition PR Newswire
Jun-19-19 06:41PM  46 and You: Genetic Testing = Giant Growth Market Zacks
Jun-18-19 09:15AM  Fed Week Begins in the Green Zacks
Jun-17-19 02:53PM  Invitae Will Acquire Singular Bio For $55M Benzinga +6.71%
07:30AM  Invitae to Acquire Singular Bio to Help Increase Access to Genetic Screening in Early Pregnancy PR Newswire
Jun-14-19 09:35AM  Were Hedge Funds Right About Flocking Into InVitae Corporation (NVTA) ? Insider Monkey
Jun-12-19 08:30AM  X4 Pharmaceuticals and Invitae Announce Partnership to Provide No-Cost Genetic Testing to Patients Suspected of Primary Immunodeficiency Disease Business Wire
07:30AM  Invitae Announces ID YOUR IRD Program to Expand Access to Genetic Testing for Inherited Retinal Disorders PR Newswire
Jun-11-19 10:21AM  It's a genetic jungle out there and this Peninsula company just landed $23M to guide patients through it American City Business Journals
Jun-04-19 01:36PM  Here's Why Genetic Testing Stocks Lost as Much as 26.1% in May Motley Fool
Jun-03-19 08:56PM  Edited Transcript of NVTA earnings conference call or presentation 7-May-19 8:30pm GMT Thomson Reuters StreetEvents
09:15AM  A May to Forget Zacks
07:30AM  Invitae introduces new service to make it easier for consumers to receive the medical genetic testing that experts trust PR Newswire
May-31-19 07:30AM  Research from Invitae Demonstrates the Importance of Germline Multigene Panel Testing in Guiding Therapy for Expanding Groups of Cancer Patients PR Newswire
May-29-19 08:00AM  Horizon Therapeutics plc and Invitae Corporation Launch Urea Cycle Disorder Genetic Testing Program Business Wire
May-28-19 05:43AM  Bull of the Day: Illumina (ILMN) Zacks
May-22-19 07:30AM  Invitae to Present at the 2019 William Blair Growth Stock Conference PR Newswire
May-20-19 06:00AM  Can Invitae Succeed in Genetic Diagnostics MoneyShow
May-17-19 10:56PM  3 High-Growth Stocks That Are Just Getting Started Motley Fool
May-15-19 07:30AM  Invitae to Present at the UBS Global Healthcare Conference PR Newswire
May-09-19 10:01AM  Were Invitae's Quarterly Results Really That Bad? Motley Fool
07:46AM  These 3 revolutionary genomics companies are changing lives for patients and investors MarketWatch
May-08-19 06:14PM  2 Healthcare Innovators To Buy Now Zacks -20.16%
12:30PM  Here's Why Invitae Got Crushed Today Motley Fool
May-07-19 11:23PM  Invitae Corp (NVTA) Q1 2019 Earnings Call Transcript Motley Fool
07:45PM  Invitae (NVTA) Reports Q1 Loss, Lags Revenue Estimates Zacks
06:41PM  Invitae: 1Q Earnings Snapshot Associated Press
04:52PM  Invitae stock falls more than 10% after revenue miss MarketWatch
04:05PM  Invitae Reports 47% Growth in Quarterly Revenue and Volume Year-Over-Year PR Newswire
May-03-19 11:23AM  Hedge Funds Have Never Been This Bullish On InVitae Corporation (NVTA) Insider Monkey
07:30AM  New Study From Invitae Highlights the Importance of Multigene Genetic Testing for Uterine Cancer Patients PR Newswire
Apr-30-19 10:32AM  Will Invitae (NVTA) Report Negative Earnings Next Week? What You Should Know Zacks
Apr-27-19 09:15AM  Strong GDP Helps S&P, NASDAQ Back to New Highs Zacks
Apr-23-19 07:30AM  Invitae to announce first quarter 2019 financial results on May 7, 2019 PR Newswire
Apr-22-19 10:17AM  Cerner (CERN) to Report Q1 Earnings: What's in the Offing? Zacks
Apr-19-19 02:48PM  Top Gene-Sequencing Stocks for 2019 Motley Fool
Apr-18-19 03:58PM  5 Must-See Stock Charts for Monday: CGC, PINS, NVTA, UNP, BX InvestorPlace
Apr-17-19 10:03AM  What Does Invitae Corporation's (NYSE:NVTA) Balance Sheet Tell Us About It? Simply Wall St. -8.77%
Apr-09-19 03:33PM  These Cannabis and China ETFs are Leading the 2019 Rally Investopedia
Apr-07-19 09:05AM  3 High-Growth Genomics Stocks You Can Buy Motley Fool
Apr-05-19 04:04PM  5 Top Stock Trades for Monday: JD, NVTA, SBUX, SPOT, OXY InvestorPlace +5.56%
Apr-04-19 12:46PM  Why Genetic Screening Stock Invitae Skyrocketed 16.4% in March Motley Fool
Apr-02-19 07:30AM  Research Underscores Need for Updated Guidelines to Include Multigene Testing for Cancer Patients PR Newswire
Mar-29-19 08:46AM  Twilio Stock Is a Must Buy on Any Market Correction InvestorPlace
Mar-28-19 12:11PM  7 Mid-Cap Growth Stocks That Could Be the Next Amazon or Netflix InvestorPlace
09:49AM  3 Small Biotech Stocks Hitting New Highs Investopedia
Mar-27-19 01:13PM  8 Genomic Testing Stocks That Can Ease the Sting of Theranos InvestorPlace
Mar-22-19 11:39AM  Harry Boxer: 3 biotech stocks with momentum MarketWatch -8.54%
Mar-18-19 09:46AM  What Should You Know About Invitae Corporations (NYSE:NVTA) Earnings Trajectory? Simply Wall St.
12:00AM  About to Buy Penny Stocks? Look at These 3 Companies First Motley Fool
Mar-14-19 07:30AM  Invitae to Present at the Oppenheimer 29th Annual Healthcare Conference PR Newswire
Mar-12-19 06:12AM  Invitae Stock Is Hot Right Now And Heres Why It Will Only Get Hotter InvestorPlace
Mar-11-19 12:59PM  Here's Why Genetic Testing Stocks Rose as Much as 42.9% in February Motley Fool +7.92%
09:16AM  Invitae (NVTA) Scales a New 52-Week High on Solid Prospects Zacks
Mar-08-19 03:22PM  Watch CNBC's interview with Invitae CEO about genetic testing CNBC Videos
Mar-07-19 07:30AM  Recent Analysis Shows Invitae, Check Point Software Technologies, Ebix, CenturyLink, Republic Services, and Costamare Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire +5.52%
Mar-06-19 09:31PM  Invitae Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares of Common Stock PR Newswire
Mar-05-19 08:19PM  Invitae Announces Pricing of Public Offering of Common Stock PR Newswire
Mar-04-19 06:30PM  Today's After-Hours Moves: Salesforce and Invitae Stocks Decline Motley Fool
05:24PM  Stocks making the biggest moves after hours: Salesforce, GameStop and more CNBC
04:07PM  Invitae Announces Proposed Public Offering of Common Stock PR Newswire
Feb-26-19 07:30AM  Behind the Seizure Program Expansion Helps Speed the Diagnosis of Genetic Epilepsy in Younger Children Experiencing Unprovoked Seizures PR Newswire
Feb-25-19 07:54PM  Invitae: Buy at the High? Motley Fool
Feb-22-19 07:46AM  3 Stocks That Have Doubled, and Still Have Room to Grow Motley Fool
Feb-20-19 09:42PM  Edited Transcript of NVTA earnings conference call or presentation 19-Feb-19 9:30pm GMT Thomson Reuters StreetEvents +13.63%
04:06PM  5 Top Stock Trades for Thursday: CVS, NVTA and HSIC Earnings InvestorPlace
09:12AM  3 Small Biotechs to Watch as Earnings Season Winds Down TheStreet.com
02:30AM  Noventa Ltd (NVTA) Q4 2018 Earnings Conference Call Transcript Motley Fool
Feb-19-19 04:58PM  Invitae: 4Q Earnings Snapshot Associated Press
04:05PM  Invitae More Than Doubles Annual Volume and Revenue Year-Over-Year, Delivering 117% in Revenue Growth Driven by 102% Growth in Volume in 2018 PR Newswire
02:30PM  Invitae Corp. to Host Earnings Call ACCESSWIRE
Feb-13-19 04:06PM  5 Top Stock Trades for Thursday: NVTA, MU, NVDA, AAPL, TWLO InvestorPlace +7.56%
07:45AM  Recent Analysis Shows General Mills, Paycom Software, Invitae, Jagged Peak Energy, John B. Sanfilippo & Son, and Intrepid Potash Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
07:30AM  Invitae to Present at the 8th Annual SVB Leerink Global Healthcare Conference PR Newswire
Feb-12-19 10:30AM  Invitae (NVTA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
08:48AM  Is the Options Market Predicting a Spike in Invitae (NVTA) Stock? Zacks
07:30AM  Invitae Launches Non-Invasive Prenatal Screening (NIPS), Offering In-Depth Genetic Information in Early Pregnancy PR Newswire
Feb-08-19 10:33PM  Here's Why Genetic Testing Stocks Rose as Much as 31.8% in January Motley Fool
10:40AM  4 Disruptive Healthcare Stocks You've Never Heard Of Motley Fool
Feb-07-19 02:52PM  How Many Insiders Sold Invitae Corporation (NYSE:NVTA) Shares? Simply Wall St.
12:00PM  New Study Finds Disease-Causing Variants More Common in Men with Prostate Cancer Than Previously Thought PR Newswire
Feb-03-19 10:19AM  3 Top Stocks That Aren't on Wall Street's Radar Motley Fool
Jan-29-19 07:30AM  Invitae to announce fourth quarter and year-end 2018 financial results on February 19, 2019 PR Newswire
Jan-07-19 11:23AM  Here's Why Invitae Gained as Much as 16% Today Motley Fool +16.44%
07:30AM  Invitae reports 2018 preliminary financial results, delivering more than 100% volume and revenue growth in 2018; projects sustained growth in expanding markets through 2019 and beyond PR Newswire
Dec-27-18 12:27PM  3 Gene Therapy Stocks to Play Biotechs Future InvestorPlace
Dec-20-18 04:31PM  Invitae to Present at the 37th Annual J.P. Morgan Healthcare Conference PR Newswire -9.11%
Invitae Corporation, a genetic information company, processes DNA-containing samples, analyzes information related to patient-specific genetic variation, and generates test reports for clinicians and their patients in the United States, Canada, and internationally. Its tests include genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders, and other hereditary conditions; and screening and testing services in reproductive health, including preimplantation and carrier screening for inherited disorders, prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. The company also operates AltaVoice, a platform for collecting, curating, coordinating, and delivering data from patients and clinicians; and CancerGene Connect, an end-to-end platform for collecting and managing genetic family histories to deliver personalized genetic risk information. It serves patients, healthcare providers, and biopharma and advocacy partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stueland KatherineChief Commercial OfficerJul 15Sale22.493,78985,231170,318Jul 16 05:49 PM
Stueland KatherineChief Commercial OfficerJun 13Sale19.363,78973,356174,107Jun 14 09:32 PM
Scott Randal WExecutive ChairmanMay 28Sale17.6030,000528,0273,490,669May 30 07:23 PM
Stueland KatherineChief Commercial OfficerMay 20Sale18.216,474117,892177,896May 22 08:08 PM
Brida ThomasGeneral CounselMay 20Sale18.212,14639,079109,533May 22 08:06 PM
BENDEKGEY E LEEChief Operating OfficerMay 20Sale18.216,851124,757161,588May 22 08:03 PM
George Sean EPresident & CEOMay 20Sale18.2124,282442,175480,007May 22 08:02 PM
Guyer Shelly DChief Financial OfficerMay 20Sale18.039,513171,539147,352May 22 07:59 PM
Nussbaum Robert LChief Medical OfficerMay 20Sale18.217,202131,148166,567May 22 07:58 PM
Stueland KatherineChief Commercial OfficerMay 15Sale18.361,00018,360184,370May 17 07:58 PM
BENDEKGEY E LEEChief Operating OfficerMay 14Sale18.784,65787,439168,439May 15 07:28 PM
Stueland KatherineChief Commercial OfficerApr 16Sale25.231,00025,230185,370Apr 17 08:17 PM
Stueland KatherineChief Commercial OfficerMar 15Sale23.491,00023,490186,370Mar 19 09:24 PM
Nussbaum Robert LChief Medical OfficerMar 08Option Exercise9.9010,00099,000173,769Mar 12 07:17 PM
Guyer Shelly DChief Financial OfficerFeb 27Sale20.004,00080,018156,865Mar 01 07:24 PM
Stueland KatherineChief Commercial OfficerFeb 27Sale19.611,00019,610187,370Mar 01 07:21 PM
Dumond PattySee RemarksFeb 27Sale19.715,00098,54088,811Mar 01 07:20 PM
BENDEKGEY E LEEChief Operating OfficerFeb 26Sale19.624,65091,213173,096Feb 27 09:26 PM
Scott Randal WExecutive ChairmanFeb 25Sale19.1030,000572,9973,520,669Feb 27 02:13 PM
Dumond PattySee RemarksJan 16Sale15.003,00045,00093,811Jan 18 05:37 PM
Guyer Shelly DChief Financial OfficerJan 16Sale14.494,00057,968160,865Jan 18 05:34 PM
Stueland KatherineChief Commercial OfficerJan 15Sale13.591,00013,590188,370Jan 16 04:39 PM
Nussbaum Robert LChief Medical OfficerJan 10Sale14.015,22273,153163,769Jan 14 09:13 PM
Stueland KatherineChief Commercial OfficerDec 17Sale11.441,00011,437189,370Dec 19 08:08 PM
AGUIAR ERICDirectorNov 27Sale13.5010,000135,0000Nov 28 07:17 PM
Dumond PattySee RemarksNov 16Sale12.902,00025,80096,811Nov 20 07:46 PM
Dumond PattySee RemarksSep 20Sale16.513555,86198,811Sep 20 07:00 PM
Dumond PattySee RemarksSep 18Sale16.672904,83499,166Sep 20 07:00 PM
Stueland KatherineChief Commercial OfficerSep 09Sale13.625958,104191,963Sep 11 08:55 PM